Literature DB >> 21642736

Oxybutynin for treatment of nocturnal enuresis in children.

Bat-Chen Friedman1, Boris Friedman, Ran D Goldman.   

Abstract

QUESTION: A 7-year-old child and his parents visit my clinic owing to the child's frequent bed-wetting. During the day, he has no problem controlling his urination. The family has tried behavioural methods but has failed to achieve dryness during the night. They ask to begin medical treatment. Is oxybutynin a safe and effective drug for treating nocturnal enuresis? ANSWER: Oxybutynin is an anticholinergic drug that has not been proven to be effective for treatment of nocturnal enuresis not accompanied by daytime symptoms, such as urgency. It can be added as a second-line drug and is effective for treating children with both daytime and nighttime wetting. Nevertheless, its common adverse effects, which can involve the central nervous system, should be considered when deciding whether or not to use it, especially in young children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642736      PMCID: PMC3093588     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

Review 1.  Treatment of childhood nocturnal enuresis: an examination of clinically relevant principles.

Authors:  R Butler; A Stenberg
Journal:  BJU Int       Date:  2001-10       Impact factor: 5.588

2.  Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.

Authors:  Paula Gish; Andrew D Mosholder; Melissa Truffa; Rosemary Johann-Liang
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

3.  Oxybutynin: is it safe?

Authors:  R J Baigrie; J P Kelleher; D P Fawcett; A W Pengelly
Journal:  Br J Urol       Date:  1988-10

4.  Oxybutynin, desmopressin and enuresis.

Authors:  T Nevéus
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

Review 5.  Muscarinic receptor antagonists in the treatment of overactive bladder.

Authors:  C R Chapple
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

Review 6.  Functional daytime incontinence: pharmacological treatment.

Authors:  K Hjälmås; G Passerini-Glazel; M L Chiozza
Journal:  Scand J Urol Nephrol Suppl       Date:  1992

7.  Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

Authors:  A Pietzko; W Dimpfel; U Schwantes; P Topfmeier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Nocturnal enuresis: medical management.

Authors:  Anju A Mammen; Fernando A Ferrer
Journal:  Urol Clin North Am       Date:  2004-08       Impact factor: 2.241

9.  Improvements in self-concept after treatment of nocturnal enuresis: randomized controlled trial.

Authors:  M E Moffatt; C Kato; I B Pless
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

10.  Oxybutynin efficacy in the treatment of primary enuresis.

Authors:  J S Lovering; S E Tallett; J B McKendry
Journal:  Pediatrics       Date:  1988-07       Impact factor: 7.124

View more
  3 in total

1.  Desmopressin, Imipramine, and Oxybutynin in the Treatment of Primary Nocturnal Enuresis: A Randomized Clinical Trial.

Authors:  Maryam Seyfhashemi; Raheb Ghorbani; Abbas Zolfaghari
Journal:  Iran Red Crescent Med J       Date:  2015-07-01       Impact factor: 0.611

2.  Desmopressin versus Oxybutynin for Nocturnal Enuresis in Children in Bandar Abbas: A Randomized Clinical Trial.

Authors:  Kambiz Ghasemi; Maryam Esteghamati; Malihe Mohammadzadeh; Shahram Zare
Journal:  Electron Physician       Date:  2016-03-25

3.  Comparative, prospective, and randomized study between urotherapy and the pharmacological treatment of children with urinary incontinence.

Authors:  Renata Martins Campos; Antonio Gugliotta; Osamu Ikari; Maria Carolina Perissinoto; Adélia Correia Lúcio; Ricardo Miyaoka; Carlos Arturo Levi D'Ancona
Journal:  Einstein (Sao Paulo)       Date:  2013 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.